Our whitepaper provides examples to researchers of per-study life cost estimate (in-life study costs only) between key rat strains.
For instance, a study model sample featured the economic impact of the RccHan®:WIST rat versus the CRL:CD®(SD) rat in both a 90-day repeated dose toxicity study and a 104 week carcinogenicity study. When compared to the CRL:CD®(SD) rat, the lower body weight, robust nature and improved survival rate of the RccHan®:WIST rat should translate into lower study costs and improved animal welfare.
Three key benefits of presented in the whitepaper:
- Maximize your study results
- Decrease study costs
- Enhance animal welfare
